Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8

Bioorg Med Chem Lett. 2012 Jan 1;22(1):723-8. doi: 10.1016/j.bmcl.2011.10.066. Epub 2011 Oct 25.

Abstract

A series of C-H functionalisation plate-based chemical screens and other C-H activation protocols were developed for the chemical diversification of drug molecules. In this Letter, metalloporphyrin and other catalytic oxidation systems are described in addition to chlorination. Mifepristone and antalarmin are used as substrates. The products obtained and the biological data demonstrate the potential utility of this approach.

MeSH terms

  • Biomimetics
  • Carbon / chemistry
  • Chemistry, Pharmaceutical / methods*
  • Chlorine / chemistry
  • Drug Design
  • Humans
  • Hydrogen / chemistry
  • Inhibitory Concentration 50
  • Metalloporphyrins / chemistry
  • Metals / chemistry
  • Microsomes, Liver / drug effects
  • Mifepristone / pharmacology*
  • Models, Chemical
  • Oxygen / chemistry
  • Pyrimidines / pharmacology*
  • Pyrroles / pharmacology*
  • Structure-Activity Relationship

Substances

  • Metalloporphyrins
  • Metals
  • Pyrimidines
  • Pyrroles
  • antalarmin
  • Mifepristone
  • Chlorine
  • Carbon
  • Hydrogen
  • Oxygen